JACLYN FULLER: Open Payments
NPI 1851668271 · ALABASTER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,873 in 137 payments from 19 companies in 2025. Trend: 2023 $2,886 · 2024 $3,393 · 2025 $2,873
Food & beverage: $2,873
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $635 |
| Janssen Biotech, Inc. | 14 | $375 |
| Ardelyx, Inc. | 15 | $353 |
| Madrigal Pharmaceuticals | 12 | $266 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $217 |
| Regeneron Healthcare Solutions, Inc. | 6 | $169 |
| GENZYME CORPORATION | 6 | $143 |
| Phathom Pharmaceuticals, Inc. | 10 | $131 |
| Gilead Sciences, Inc. | 5 | $128 |
| Aimmune Therapeutics, Inc. | 5 | $90 |
Products named: TREMFYA, IBSRELA, RINVOQ, DUPIXENT, REZDIFFRA, ENTYVIO, LINZESS, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
